U.S. Government Selects Biothera Compounds For National Radiation Countermeasure Evaluation  
9/18/2006 1:37:02 PM

EAGAN, Minn., Sept. 18 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has selected two Biothera drug candidates for research in a new program designed to identify and facilitate the development of radiation and nuclear medical countermeasures.